An increased release of pro‐inflammatory cytokines by Th1 and Th17 cells (eg IL‐6 and IL‐17) was documented in COVID‐19 patients, associated with the inflammatory condition.23, 24, 25. This evidence concerns the gene IL6 and COVID-19.